Fonar (FONR) Price-to-Tangible-Book

: 0.67 (As of Today)

View and export this data going back to 1981. Start your Free Trial

As of today (2024-04-23), Fonar's share price is $16.20. Fonar's Tangible Book per Share of Dec. 2023 for the quarter that ended in Dec. 2023 was $24.22. Hence, Fonar's Price to Tangible Book Ratio of today is 0.67.

The historical rank and industry rank for Fonar's Price-to-Tangible-Book or its related term are showing as below:

FONR' s Price-to-Tangible-Book Range Over the Past 10 Years
Min: 0.65 Med: 1.32 Max: 13.25
Current: 0.67

During the past 13 years, Fonar's highest Price to Tangible Book Ratio was 13.25. The lowest was 0.65. And the median was 1.32.

FONR's Price-to-Tangible-Book is ranked better than
88.76% of 169 companies
in the Medical Diagnostics & Research industry
Industry Median: 2.51 vs FONR: 0.67

A closely related ratio is called PB Ratio. As of today, Fonar's share price is $16.20. Fonar's Book Value per Sharefor the quarter that ended in Dec. 2023 was $25.39. Hence, Fonar's P/B Ratio of today is 0.64.

Fonar Price-to-Tangible-Book Historical Data

The historical data trend for Fonar's Price-to-Tangible-Book can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Fonar Annual Data

Trend

Jun14

Jun15

Jun16

Jun17

Jun18

Jun19

Jun20

Jun21

Jun22

Jun23

Price-to-Tangible-Book

1.30

1.19

0.91

0.71

0.75

Fonar Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Price-to-Tangible-Book																0.76	0.72	0.75	0.66	0.81

Competitive Comparison

For the Diagnostics & Research subindustry, Fonar's Price-to-Tangible-Book, along with its competitors' market caps and Price-to-Tangible-Book data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Fonar Price-to-Tangible-Book Distribution

For the Medical Diagnostics & Research industry and Healthcare sector, Fonar's Price-to-Tangible-Book distribution charts can be found below:

* The bar in red indicates where Fonar's Price-to-Tangible-Book falls into.

Fonar Price-to-Tangible-Book Calculation

Fonar's price-to-tangible-book ratio for today is calculated as:

Price to Tangible Book	=	Share Price	/	Tangible Book per Share (Q: Dec. 2023 )
	=	16.20	/	24.219
	=	0.67

It can also be calculated from the numbers for the whole company:

Price to Tangible Book	=	Market Cap	/	Tangible Equity
	=	Market Cap	/	(Total Stockholders Equity	-	Preferred Stock	-	Intangible Assets)

A closely related ratio is called PB Ratio. The difference between Price-to-Tangible-Book Ratio and PB Ratio is that book value other than intangibles are used in the calculation.

Be Aware

Some businesses have very light assets, such as software companies or insurance agencies. The Price-to-Book Ratio does not work well for these companies. Some companies even have negative equity, so the Price-to-Book Ratio cannot be applied to them.

Fonar Price-to-Tangible-Book Related Terms

Thank you for viewing the detailed overview of Fonar's Price-to-Tangible-Book provided by GuruFocus.com. Please click on the following links to see related term pages.

Fonar (FONR) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Fonar Corp (NAS:FONR) » Definitions » Price-to-Tangible-Book

Comparable Companies

Traded in Other Exchanges

FOAA:Germany

Address

110 Marcus Drive, Melville, NY, USA, 11747

Website

https://www.fonar.com

Fonar Corp is a United States-based company which is engaged in the business of designing, manufacturing, selling and servicing magnetic resonance imaging (MRI) scanners, which utilize MRI technology for the detection and diagnosis of human disease, abnormalities, other medical conditions, and injuries. The company operates through two segments namely Manufacturing and servicing of medical equipment; and the Management of diagnostic imaging centers, which generates a vast majority of the revenue. The company's areas of operations are principally in the United States. It also exports to the United Arab Emirates, England, and Germany.

Executives

Timothy Raymond Damadian	director, officer: CEO, President & Treasurer	110 MARCUS DR., MELVILLE NY 11747
Luciano B Bonanni	officer: Exec VP, COO & PFO	110 MARCUS DR., MELVILLE NY 11747
Raymond V Damadian	director, officer: president	31 FAIRBANKS BLVD, WOODBURY NY 11797
Robert J Janoff	director	32 OSAGE DRIVE, HUNTINGTON STATION NY 11746
Data Charles O	director	347 LINCOLN AVENUE, BEAVER PA 15009
Claudette Chan	director	145 WEST 86TH STREET, APT. 15B, NEW YORK NY 10024
David B Terry	officer: Secretary	BOX 1439, EAST QUOGUE NY 11942
Robert Djerejian	director	303 EAST 57TH STREET, APT 16LA, NEW YORK NY 10022